Pioglitazone: a promising therapy for psoriasis

被引：46

作者：

Robertshaw, H ^{[1
]}

Friedmann, PS ^{[1
]}

机构：

[1] Royal S Hants Hosp, Dept Dermatol, Southampton SO14 0YG, Hants, England

来源：

BRITISH JOURNAL OF DERMATOLOGY | 2005年 / 152卷 / 01期

关键词：

D O I：

10.1111/j.1365-2133.2005.06369.x

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

引用

收藏

页码：189 / 191

页数：3

相关论文

共 5 条

[1] Rosiglitazone inhibits proliferation, motility, and matrix metalloproteinase production in keratinocytes
Bhagavathula, N
Nerusu, KC
Lal, A
Ellis, CN
Chittiboyina, A
Avery, MA
Ho, CI
Benson, SC
Pershadsingh, HA
Kurtz, TW
Varani, J
[J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2004, 122 (01) : 130 - 139
[2] Troglitazone improves psoriasis and normalizes models of proliferative skin disease -: Ligands for peroxisome proliferator-activated receptor-γ inhibit keratinocyte proliferation
Ellis, CN
Varani, J
Fisher, GJ
Zeigler, ME
Pershadsingh, HA
Benson, SC
Chi, YQ
Kurtz, TW
[J]. ARCHIVES OF DERMATOLOGY, 2000, 136 (05) : 609 - 616
[3] Differences in lipid profiles of patients given rosiglitazone followed by pioglitazone
LaCivita, KA
Villarreal, G
[J]. CURRENT MEDICAL RESEARCH AND OPINION, 2002, 18 (06) : 363 - 370
[4] Treatment of psoriasis with troglitazone therapy
Pershadsingh, HA
Sproul, JA
Benjamin, E
Finnegan, J
Amin, NM
[J]. ARCHIVES OF DERMATOLOGY, 1998, 134 (10) : 1304 - 1305
[5] 2002, PRESCRIRE INT, V11, P170